Clin2
NCT07606976Worth exploringNot yet recruiting

Study of a new medicine in healthy adults

Healthy

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are aged between 18 and 45 years.
  • You are generally healthy, with no major medical conditions.
  • You have normal levels of immunoglobulins (infection-fighting proteins) in your blood.
  • You have not had a severe allergic reaction in the past.
  • You must agree to use effective birth control and avoid donating sperm or eggs for at least 6 months after the dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07487545Not yet recruiting· Phase 1
Testing a single infusion of an investigational drug in healthy adults

This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.

Charlestown, New South Wales
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07366866Recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.

Shanghai, Shanghai Municipality
NCT07473570Recruiting· Phase 1
Safety study of GS3-007a in healthy adults

This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.

Shanghai, Shanghai Municipality
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.